The financing agreement with Winance is being terminated
Brighter has signed the termination of the financing agreement with investment company Winance announced by Brighter on May 28, 2019.
”We are terminating the financing agreement with Winance, to instead finance our global commercialization activities with the recently announced share issue (the benefit issue) directed to the shareholders,” says Henrik Norström, CEO of Brighter.
About Brighter AB (publ)
Brighter is a health-tech company from Sweden with a vision of a world where managing chronic diseases is no longer a struggle. We believe a data-centric approach is key to provide smarter care for chronic conditions. Our daily-care solutions facilitate the flow of real-life treatment data between chronic-disease patients, their loved ones and their care providers – improving quality of life, easing the burden on healthcare systems, and opening new opportunities for data-driven research. Brighter is certified under ISO 13485. In 2019 the company won the Swecare Rising Stars Award. https://brighter.se/
The Company's shares are listed on Nasdaq First North Growth Market/BRIG. Brighter’s Certified Adviser is Eminova Fondkommission AB, +46 (0)8 – 684 211 10, email@example.com, www.eminova.se.
For further information, please contact:
Henrik Norström, CEO
Phone: +46 733 40 30 45
This information is information that Brighter AB is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact persons set out above, at 10:37 CET on November 29, 2019.